Delivery Order SPE2DB20D1100-SPE2DB25FE4G7
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,753.52 to AmerisourceBergen Drug Corp for the supply of Pregnyl 10,000 unit vials, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $2,418.00 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for Pregnyl 10,000 unit vials, with an ultimate completion date of June 2, 2025. This non-set-aside, firm fixed price delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999...
- The Defense Logistics Agency awarded a $2,418 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Pregnyl 10,000 unit vials, with an ultimate completion date of September 10, 2025. This non-set-aside contract was competitively awarded on September 9, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Pregnyl 10,000 unit vials, with a ceiling value of $1,813.50. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's existing contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,813.50 to AmerisourceBergen Drug Corp for Pregnyl 10,000 unit vials, a human chorionic gonadotropin medication. The contract is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and represents a non-competitive set-aside award to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,208.42 to AmerisourceBergen Drug Corp for 10,000-unit vials of Pregnyl, a human chorionic gonadotropin medication. The contract, awarded on April 24, 2025, with an ultimate completion date of April 25, 2025, utilizes firm fixed-price pricing and represents a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Pregnyl 10,000 Unit Vials with a ceiling value of $3,022.50. This is a firm fixed price delivery order with an ultimate completion date of July 21, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,022.50 to AmerisourceBergen Drug Corp for the supply of Pregnyl 10,000 unit vials. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 20, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,418.00 for 10,000 unit vials of Pregnyl on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price contract represents a non-set-aside award executed under AmerisourceBergen's comprehensive Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $3,627.00 to AmerisourceBergen Drug Corp for Pregnyl 10,000 unit vials, with performance completed by July 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE4G7Delivery Order
The Defense Logistics Agency awarded a $1,370.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Pregnyl 10,000 unit vials, with an ultimate completion date of September 4, 2025. This non-set-aside contract is a child order placed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, the company's headquarters location, where AmerisourceBergen maintains its corporate operations and distribution capabilities. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, regularly fulfills medical supply requirements through the DLA's pharmaceutical procurement framework. The delivery order reflects the company's established role as a preferred supplier for military and federal healthcare systems, delivering specialty medications, vaccines, and other pharmaceutical commodities that support Defense Health Agency operations and broader government medical supply needs. The expedited completion timeline—with award and completion dates separated by one day—indicates this represents urgent or routine replenishment demand for human chorionic gonadotropin products within the federal healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/3/25 |